Sanofi-Aventis

Headquarters location: 174 avenue de France 75635 Paris Cedex 13 Tel. 33-1-53-77-44-45 Job offers, investor relations: www.sanofi-aventis.com Email: investor-relations@sanofi-synthelabo.com

Sanofi Aventis belongs to shareholder country     % source Employés 1 KPC Corp 6.19 L'Oréal 10.41 Sanofi-Aventis 4.4 AFP State Street Corp. 5 Boursier.c. Total SA 12.99 Sanofi Aventis owns subsidiary country     % source Aventis SA 100 Genfit Les Echos Hoechst AG 100 Cercle Fin. Sanofi 100 Sanofi-Aventis 4.4 AFP Zentiva 25 Financial .	Brands name items photo compare the prices Allegra Ethishop Aprovel Ethishop Astra-Synthélabo Ethishop Chinoin Rt Ethishop Copaxone Ethishop Eloxatine Ethishop Irex Ethishop Lactacyd Ethishop Lantus Ethishop Lipofactor Ethishop Lovenox Ethishop Mitosyl Ethishop Plavix Ethishop Sanofi-Aventis Ethishop Sanofi-Synthelabo Ethishop Stilnox Ethishop Taxotere Ethishop Tritace Ethishop Shop local, ethical and at the best price on Ethishop !
« ETHICAL » RATING OF SANOFI_AVENTIS , group and subsidiaries [?] 4% Job: 4% of company's jobs cut since 1998 4 Environment: 4 major pollution(s) 12 Delinquency: 12 act(s) of financial or trade delinquency 3 Tax haven, secret bank account, shell companies: operates in 3 offshore financial center(s) 25 Sales: more than 25 billion(s) dollars/euros in annual sales 4 Net profit: more than 4 billion(s) dollars/euros in cumulated net profit since 1998 806 Top management: earns 806 times the median income in the United States (32000 US$/year) 10 Influence: 10 act(s) of direct corruption or lobbying 3 Advertising & marketing: 3 dubious practice(s) Full profile >>>
Relevance: business & market share year business source 2007 Sanofi-Aventis SA, France's largest drugmaker 2007 Sanofi-Aventis is France's largest drugmaker. 2006 Sanofi-Aventis is the world's fourth-largest pharmaceutical group. Les Echos 2006 Sanofi-Aventis sells 23% of the vaccines bought in the world. Les Echos 2004 The world's third-largest pharmaceutical company with 70 plants in the world, 19 of which in France. World locations & Manufacturing country incentive : address & contact : production type source   Great Valley, Pennsylvanie : R&D Les Echos   Montpellier : R&D Les Echos   Toulouse : R&D Les Echos   Chilly-Mazarin : R&D Les Echos   Bagneux : R&D Les Echos   Porcheville : R&D Les Echos   Chinoin Rt : Les Echos   Alnwick : R&D Les Echos The map of tax haven, secret accounts and shell companies Sanofi Aventis is managed by year name photo position; compensation source 2004Laimay, Marie-Hélène Chief Financial Officer; Boursorama 2002Dehecq, Jean-François Chief Executive Officer; salary: 1.9 million Eu€; stock-options: 6 million Eu€; Les Echos 2001Dehecq, Jean-François Chief Executive Officer; salary: 4 million Eu€; L'humanité 1999Barbier de la Serre, René Director; 1999Castaigne, Robert Director; 1999De Gennes, Pierre-Gilles Director; 1999Desmarest, Thierry Director; 1999Martin, Pierre Castres Saint Director; 1999Owen-Jones, Lindsay Director; 1999Weymuller, Bruno Director; 1998Guérin, Hervé Chief Executive Officer; Forbes Highest paid executives in 2007 Advertising & marketing year dubious practice : image source 2005 Arguable partnership: S'est allié à la fondation Drugs for Neglected Diseases Initiative pour la mise au point et la distribution d'ici 2006 d'un traitement à prix coûtant contre le paludisme. Le paludisme est une maladie délaissée par les centres de recherche des grands laboratoires privés. « On n'arrive pas à trouver une rentabilité, qui est à la base de nos projets de recherche, tout le monde le comprendra », explique Philippe Baetz, vice-président de Sanofi-Aventis.: value: Health; Libération 2004 slogan: Nous refusons l'idée de ne pas développer les médicaments de demain pour un simple problème de taille; 1999 slogan: L'essentiel, c'est la santé; Dubious practices in 2007

Made by year employees <> social impact : country source 2008 100000 -380 Internal restructuring: Sanofi-Aventis cuts 380 jobs of medical representatives in Germany.: Germany L'Expansio. 2007 -40 Internal restructuring: Canada Les Echos 2007 -118 Internal restructuring: Sanofi-Aventis restructures its Neuville-on-Saone factory because of the fall of the sales of the Ketek drug.: France Les Echos 2005 -504 Merger/Acquisition: Suite à la fusion Aventis-Sanofi, 500 salariés de plus de 55 ans ont accepté une cessation anticipée, avec 70% du salaire net.: France Les Echos 2004 -330 Internal restructuring: La Vie Fin. 2004 99700 2002 32436 2001 30514 2000 29200 Layoff plans and labour conditions in 2007 Environmental impact year country : consequences source 2006 France : The International Chamber of Commerce of Paris confirmed the "environmental responsibility" of Sanofi for the underground pollution with mercury of the Vieux-Thann site. Les Echos Pollutions in 2007 Influence year purpose : intermediary/lobby : institution source 2000 Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate Washington. 2000 lift the ban on bovine growth hormon : FEDESA : : European Commission translate Fedesa 2000 Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate EFPIA Influence in 2007 Financials year financial misdemeanor sales income buyback source 2007   28.05 6.96   billion Eu€ 2007 Sanofi pays US$190 million to the US Department of Justice to settle allegations of fraud in the pricing and marketing of a drug used for cancer treatment side effects. From September 1997 to June 2004, Sanofi's subsidiary Aventis allegedly artificially inflate the price of the drug Anzemet, increasing the cost of government reimbursements for the drug.     AP 2006   27.75 6.57   billion Eu€ 2004   1.53 billion Eu€ Boursier.c. 2004   25   billion US$ 2003   8.72 1.1   billion Eu€ 2003   1 billion Eu€ AFP 2003   0.14 billion Eu€ Boursier.c. 2002   7.45 1.58   billion Eu€ 2001   6.49 0.98   billion Eu€ 2000   5.96 0.62   billion Eu€ 1999   5.35   billion Eu€ Financial delinquency in 2007

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >

---

---

---

Further investigation

Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.

Name (or ninckname)*		Email
Title*		Link to document online
Information*
Alert me of answers by email			* required field
Please copy the antispam code:

The 5 latest validated comments

Aig american group   AIG's Loss, Capital Needs Renew Doubts About Sullivan's Tenure - Friday 9 May 2008 at 08h30

Target   Target writes off 8.1% of its annualized credit card debt in March - Friday 2 May 2008 at 11h07

Dell computer   Dell confirms plan to cut 250 Irish jobs - Friday 2 May 2008 at 08h50

Henry   leatest profile of hery sy - Tuesday 29 April 2008 at 07h08

Dow jones   Wall Street Journal managing editor stepping down - Tuesday 22 April 2008 at 08h09

All comments